Tags

Type your tag names separated by a space and hit enter

Use of countercurrent chromatography during isolation of 6-hydroxyluteolin-7-O-β-glucoside, a major antioxidant of Athrixia phylicoides.
J Chromatogr A. 2011 Sep 09; 1218(36):6179-86.JC

Abstract

Athrixia phylicoides, an indigenous South African herbal tea, has potential as a source of nutraceutical antioxidant extracts. Countercurrent chromatography (CCC) was employed as part of a multi-step process to isolate one of the major antioxidant compounds in A. phylicoides extracts. Antioxidant activity of the extracts was comparable to commercial nutraceutical extracts from Aspalathus linearis and Cyclopia spp. in a range of assays. The extracts were tested for radical scavenging (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) di-ammonium radical cation (ABTS·⁺) scavenging, 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) scavenging and oxygen radical absorbance capacity (ORAC)), ferric reducing antioxidant potential (FRAP) and iron chelating activity, as well as inhibition of microsomal lipid and linoleic acid emulsion oxidation. After extraction optimisation, the antioxidant activity of the major phenolic compounds in an A. phylicoides extract was determined using the on-line HPLC-diode-array-DPPH and -ABTS·⁺ radical scavenging assays. Major compounds reported for the first time included chlorogenic acid, 1,3-dicaffeoylquinic acid, several hydroxycinnamic acid derivatives, including dicaffeoyl quinic acids, and an unidentified flavone-hexose. Finally, CCC was used in conjunction with liquid-liquid partitioning and semi-preparative reversed-phase HPLC to isolate 6-hydroxyluteolin-7-O-β-glucoside (a major antioxidant) and quercetagetin-7-O-β-glucoside (a minor compound present in CCC fraction containing 6-hydroxyluteolin-7-O-β-glucoside) from an A. phylicoides extract. The chemical structures of the isolated compounds were confirmed by LC high-resolution electrospray ionisation MS, as well as ¹H, ¹³C and 2D NMR spectroscopy. This is the first report of the isolation of these compounds from A. phylicoides.

Authors+Show Affiliations

Post-Harvest and Wine Technology Division, Agricultural Research Council, Infruitec-Nietvoorbij, Private Bag X5026, 7599 Stellenbosch, South Africa. debeer.dalene@gmail.comNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21236437

Citation

de Beer, Dalene, et al. "Use of Countercurrent Chromatography During Isolation of 6-hydroxyluteolin-7-O-β-glucoside, a Major Antioxidant of Athrixia Phylicoides." Journal of Chromatography. A, vol. 1218, no. 36, 2011, pp. 6179-86.
de Beer D, Joubert E, Malherbe CJ, et al. Use of countercurrent chromatography during isolation of 6-hydroxyluteolin-7-O-β-glucoside, a major antioxidant of Athrixia phylicoides. J Chromatogr A. 2011;1218(36):6179-86.
de Beer, D., Joubert, E., Malherbe, C. J., & Jacobus Brand, D. (2011). Use of countercurrent chromatography during isolation of 6-hydroxyluteolin-7-O-β-glucoside, a major antioxidant of Athrixia phylicoides. Journal of Chromatography. A, 1218(36), 6179-86. https://doi.org/10.1016/j.chroma.2010.12.096
de Beer D, et al. Use of Countercurrent Chromatography During Isolation of 6-hydroxyluteolin-7-O-β-glucoside, a Major Antioxidant of Athrixia Phylicoides. J Chromatogr A. 2011 Sep 9;1218(36):6179-86. PubMed PMID: 21236437.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of countercurrent chromatography during isolation of 6-hydroxyluteolin-7-O-β-glucoside, a major antioxidant of Athrixia phylicoides. AU - de Beer,Dalene, AU - Joubert,Elizabeth, AU - Malherbe,Christiaan J, AU - Jacobus Brand,D, Y1 - 2010/12/29/ PY - 2010/10/27/received PY - 2010/12/17/revised PY - 2010/12/21/accepted PY - 2011/1/18/entrez PY - 2011/1/18/pubmed PY - 2011/10/22/medline SP - 6179 EP - 86 JF - Journal of chromatography. A JO - J Chromatogr A VL - 1218 IS - 36 N2 - Athrixia phylicoides, an indigenous South African herbal tea, has potential as a source of nutraceutical antioxidant extracts. Countercurrent chromatography (CCC) was employed as part of a multi-step process to isolate one of the major antioxidant compounds in A. phylicoides extracts. Antioxidant activity of the extracts was comparable to commercial nutraceutical extracts from Aspalathus linearis and Cyclopia spp. in a range of assays. The extracts were tested for radical scavenging (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) di-ammonium radical cation (ABTS·⁺) scavenging, 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) scavenging and oxygen radical absorbance capacity (ORAC)), ferric reducing antioxidant potential (FRAP) and iron chelating activity, as well as inhibition of microsomal lipid and linoleic acid emulsion oxidation. After extraction optimisation, the antioxidant activity of the major phenolic compounds in an A. phylicoides extract was determined using the on-line HPLC-diode-array-DPPH and -ABTS·⁺ radical scavenging assays. Major compounds reported for the first time included chlorogenic acid, 1,3-dicaffeoylquinic acid, several hydroxycinnamic acid derivatives, including dicaffeoyl quinic acids, and an unidentified flavone-hexose. Finally, CCC was used in conjunction with liquid-liquid partitioning and semi-preparative reversed-phase HPLC to isolate 6-hydroxyluteolin-7-O-β-glucoside (a major antioxidant) and quercetagetin-7-O-β-glucoside (a minor compound present in CCC fraction containing 6-hydroxyluteolin-7-O-β-glucoside) from an A. phylicoides extract. The chemical structures of the isolated compounds were confirmed by LC high-resolution electrospray ionisation MS, as well as ¹H, ¹³C and 2D NMR spectroscopy. This is the first report of the isolation of these compounds from A. phylicoides. SN - 1873-3778 UR - https://www.unboundmedicine.com/medline/citation/21236437/Use_of_countercurrent_chromatography_during_isolation_of_6_hydroxyluteolin_7_O_β_glucoside_a_major_antioxidant_of_Athrixia_phylicoides_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0021-9673(10)01819-4 DB - PRIME DP - Unbound Medicine ER -